On Thursday, President Joe Biden said that the U.S. had licensed the technology in Covid-19 to the World Health Organization. This would enable manufacturers all over the globe to collaborate with the agency to create their own vaccines against the virus.

National Institutes of Health have licensed it stabilized spike protein technologyBiden spoke to the WHO, United Nations Medicines Patent Pool.

In vaccines, the spike protein induces an immune reaction that prompts the body’s fight against the virus. The NIH technology stores the proteins in a way that makes them more effective. Now, the WHO and Medicines Patent Pool are able to sublicense this technology to generic producers around the globe.

Biden stated that he was making available U.S. government-owned health technology, which includes stabilized spike protein used in Covid-19 vaccines.

It is a decision to share technology ahead of Thursday’s virtual Covid-19 summit in the United States. Though the spike protein technology is crucial, the vaccines also include other components — some of which are proprietary to the companies.

According to the WHO Thursday, the license would allow people living in low- or middle-income countries access to the critical technology and aid in ending the pandemic.

Through the entire pandemic, the technology that underpins the Covid vaccines was a sticking point. Although the WHO repeated its call to vaccine producers for sharing their expertise, PfizerAnd ModernaThe Medicines Patent Pool is one of U.N. public health agencies, like the WHO. They have refused to license the technology that they used to create their shots. Moderna does not enforce its patents in the 92 nations that are poorer. Although Pfizer doesn’t share the technology, the company is providing 1 billion doses to the U.S. government for distribution to the poorer countries.

WHO created a South African manufacturing center to manufacture vaccines that use the same messengerRNA technology used by Moderna and Pfizer in their shot. Because Moderna isn’t protecting its patents, South African scientists have been able to create generic versions of Moderna’s vaccine using publicly available information.

Tedros Adhanom Ghebreyesus WHO Director-General called on Moderna shareholders attending the annual meeting of the biotech company to support a resolution calling for a third party investigation regarding the feasibility of transferring technological technology.

Tedros stated that Moderna could have collaborated with him to submit the vaccine to approval for the hub at least one-year sooner. This would be a lifesaver, reduce the chance of variants, and lower the economic impact of the pandemic.

For a contribution totaling $450million, the U.S. also contributes $200 million more to the World Bank pandemic preparedness funds. An additional $20 million is provided by the United States Agency for International Development. These dollars will be used to support Covid testing and antiviral treatment in eight other countries. According to the White House, it will also increase its vaccination donations via Pfizer in order to provide booster shots and vaccines for children.

These donations pale in comparison to the $5 billion that the White House requested of Congress for funding vaccinations across the globe. Biden requested $22.5 billion for Covid funding, but Congress failed to approve it due to resistance from Republicans.

The $10 billion Covid funding package that Senators signed in April did not include any money for global vaccination campaigns. Republicans blocked Senate passage of $10 billion due to a disagreement over the decision by the Centers for Disease Control and Prevention to stop a controversial policy, Title 42, which allowed asylum seekers who crossed the border to Mexico to be returned to their homelands.